SMAD2 and cardiofaciocutaneous syndrome: In this study, we provide cellular modeling of CFC syndrome in which CFC-MSCs derived from CFC-iPSCs have a paucity of osteogenic capacity due to abnormal crosstalk between several signaling pathways, including ERK, SMAD2, and SMAD1 signaling (Figure 5d).